Effects of treatment with antimicrobial agents on the human colonic microflora

Therapeutics and Clinical Risk Management

Volumn 4, Issue 6, 2008, Pages 1343-1357

  Rafii, Fatemeh ^a   Sutherland, John B ^a   Cerniglia, Carl E ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Antibiotics; Intestinal bacteria

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFADROXIL; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTIBUTEN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; CLOXACILLIN; ERTAPENEM; GARENOXACIN; IMIPENEM; LATAMOXEF; LINEZOLID; MEROPENEM; METRONIDAZOLE; MONOBACTAM DERIVATIVE; OMEPRAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIAL VIRULENCE; COLON FLORA; DIARRHEA; DRUG EFFICACY; DRUG WITHDRAWAL; ERADICATION THERAPY; FEBRILE NEUTROPENIA; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOCOMPROMISED PATIENT; MICROBIAL COLONIZATION; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MYCOSIS; NONHUMAN; REVIEW; SURGICAL INFECTION;

EID: 61549089404     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/tcrm.s4328     Document Type: Review

References (100)

1. Adamsson I, Edlund C, Sjostedt S, et al. 1997. Comparative effects of cefadroxil and phenoxymethylpenicillin on the normal oropharyngeal and intestinal microflora. Infection, 25:154-8.
2. Adamsson I, Nord CE, Lundquist P, et al. 1999. Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother, 44:629-40.
3. Al-Nassir WN, Sethi AK, Li Y, et al. 2008. Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease. Antimicrob Agents Chemother, 52:2403-6.
4. Aldridge KE, Ashcraft D, Cambre Y, et al. 2001. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreplococcus species. Antimicrob Agents Chemother, 45:1238-43.
5. Alestig K, Carlberg H, Nord CE, et al. 1983. Effect of cefoperazone on faecal flora. J Antimicrob Chemother, 12:163-7.
6. Ambrose NS, Johnson M, Burdon DW, et al. 1985. The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile. J Antimicrob Chemother, 15:319-26.
7. Ansorg R, Rath PM, Runde V, et al. 2003. Influence of intestinal decontamination using metronidazole on the detection of methanogenic Archaea in bone marrow transplant recipients. Bone Marrow Transplant, 31:117-9.
8. Aronsson B, Möllby R, Nord CE. 1981. Occurrence of toxin-producing Clostridium difficile in antibiotic-associated diarrhea in Sweden. Med Microbiol Immunol, 170:27-35.
9. Aronsson B, Möllby R, Nord CE. 1985. Antimicrobial agent and Clostridium difficile in acute enteric disease: epidermological data from Sweden, 1980-1982. J Infect Dis, 151:476-81.
10. Arvidsson A, Alvan G, Angelin B, et al. 1992. Ceftriaxone: renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother, 10:207-15.
11. Arvidsson A, Leijd B, Nord CE, et al. 1988. Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora. Eur J Clin Invest, 18:261-6.
12. Barker PJ, Sheehan R, Teillol-Foo M, et al. 2001. Impact of gemifloxacin on the normal human intestinal microflora. J Chemother, 13:47-51.
13. Berg RD. 1996. The indigenous gastrointestinal microflora. Trends Microbiol, 4:430-5.
14. Bergan T, Nord CE, Thorsteinsson SB. 1991. Effect of meropenem on the intestinal microflora. Eur J Clin Microbiol Infect Dis, 10:524-7.
15. Birnbaum J, Kahan FM, Kropp H, et al. 1985. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/ cilastatin. Am J Med, 78:3-21.
16. Brismar B, Edlund C, Malmborg AS, et al. 1990. Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother, 34:481-3.
17. Brismar B, Edlund C, Nord CE. 1991. Comparative effects of clarithromycin and erythromycin on the normal intestinal microflora. Scand J Infect Dis, 23:635-42.
18. Brismar B, Edlund C, Nord CE. 1993a. Effect of ceflibuten on the normal intestinal microflora. Infection, 21:373-5.
19. Brismar B, Edlund C, Nord CE. 1993b. Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora. Eur J Clin Microbiol Infect Dis, 12:714-9.
20. Brumfitt W, Franklin I, Grady D, et al. 1986. Effect of amoxicillin-clavulanate and cephradine on the fecal flora of healthy volunteers not exposed to a hospital environment. Antimicrob Agents Chemother, 30:335-7.
21. Cerniglia CE, Kotarski S. 1999. Evaluation of veterinary drug residues in food for their potential to affect human intestinal microflora. J Regulatory Toxicol Pharmacol, 29:238-61.
22. D'Antonio D, Pizzigallo E, Lacone A, et al. 1996. The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. J Antimicrob Chemother, 38:839-47.
23. De La Cochetiere MF, Durand T, Lepage P, et al. 2005. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol, 43:5588-92.
24. Deneve C, Delomenie C, Bare MC, et al. 2008. Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression. J Med Microbiol, 57:732-8.
25. Eckemas SA, Grahnen A, Nord CE. 1991. Impact of dirithromycin on the normal oral and intestinal microflora. Eur J Clin Microbiol Infect Dis, 10:688-92.
26. Edlund C, Alvan G, Barkholt L, et al. 2000a. Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora. J Antimicrob Chemother, 46:741-9.
27. Edlund C, Barkholt L, Olsson-Liljequist B, et al. 1997a. Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis, 25:729-32.
28. Edlund C, Bergan T, Josefsson K, et al. 1987a. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics. Scand J Infect Dis, 19:113-21.
29. Edlund C, Beyer G, Hiemer-Bau M, et al. 2000b. Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand J Infect Dis, 32:81-5.
30. Edlund C, Brismar B, Nord CE. 1990. Effect of lomefloxacin on the normal oral and intestinal microflora. Eur J Clin Microbiol Infect Dis, 9:35-9.
31. Edlund C, Kager L, Malmborg AS, et al. 1988. Effect of ofloxacin on oral and gastrointestinal microflora in patients undergoing gastric surgery. Ear J Clin Microbiol Infect Dis, 7:13 5-43.
32. Edlund C, Lidbeck A, Kager L, et al. 1987b. Comparative effects of enoxacin and norfloxacin on human colonic microflora. Antimicrob Agents Chemother, 31:1846-8.
33. Edlund C, Nord CE. 1988a. Manipulation of the oropharyngeal and intestinal microflora by norfloxacin: microbiological and clinical aspects. Scand J Infect Dis Suppl, 56:14-21.
34. Edlund C, Nord CE. 1988b. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora. Infection, 16:8-12.
35. Edlund C, Nord CE. 1999a. Ecological effect of gatifloxacin on the normal human intestinal microflora. J Chemother, 11: 50-3.
36. Edlund C, Nord CE. 1999b. Effect of quinolones on intestinal ecology. Drugs, 58(Suppl 2):65-70.
37. Edlund C, Nord CE. 2000. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J Antimicrob Chemother, 46(Suppl A)A1-8.
38. Edlund C, Sjöstedt S, Nord CE. 1997b. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora. Scand J Infect Dis, 29:383-6.
39. Edlund C, Stark C, Nord CE. 1994. The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. J Antimicrob Chemother, 34:127-38.
40. Finegold SM. 1986. Anaerobic infections and Clostridium difficile colitis emerging during antibacterial therapy. Scand J Infect Dis Suppl, 49:160-4.
41. Gauthier G, Klein BS. 2008. Insights into fungal morphogenesis and immune evasion. Microbe, 3:416-23.
42. Gipponi M, Sciutto C, Accornero, L, et al. 1985. Assessing modifications of the intestinal bacterial flora in patients on long-term oral treatment with bacampicillin or arnoxicillin: a random study. Chemioterapia, 4:214-7.
43. Heimdahl A, Nord CE. 1982. Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract. Eur J Clin Microbiol, 1: 3 8-48.
44. Inagaki Y, Yamamoto N, Chida T, et al. 1995. The effect of DU-6859a, a new potent fluoroquinolone, on fecal microflora in human volunteers. Jpn J Antibiot, 48:368-79.
45. Kager L, Brismar B, Malmborg AS, et al. 1986. Impact of cefbuperazone on the colonic microflora in patients undergoing colorectal surgery. Drugs Exp Clin Res, 12:98 3-6.
46. Kager L, Brismar B, Malmborg AS, et al. 1988. Effect of imipenem treatment versus irnipenem surgical prophylaxis on the intestinal microflora. Int J Clin Pharmacol Res, 8:441-7.
47. Kager L, Brismar B, Malmborg AS, et al. 1989. Imipenem concentrations in colorectal surgery and impact on the colonic microflora. Antimicrob Agents Chemother, 33:204-8.
48. Kager L, Liljeqvist L, Malmborg AS, et al. 1981. Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother, 20:736-40.
49. Kager L, Malmborg AS, Nord CE, et al. 1982. The effect of short-term cefoxitin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Infection, 10:338-40.
50. Kager L, Malmborg AS, Nord CE, et al. 1983. The effect of piperacillin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Infection, 11:251-4.
51. Kennedy MJ, Volz PA. 1985. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. Sabouraudia, 23:265-73.
52. Kennedy MJ, Volz PA, Edwards CA, et al. 1987. Mechanisms of association of Candida albicans with intestinal mucosa. J Med Microbiol, 24:333-41.
53. Lambert-Zechovsky N, Bingen E, Aujard Y, et al. 1985. Impact of cefotaxime on the fecal flora in children. Infection, (13 Suppl 1): S140-S144.
54. Leigh DA. 1979. Pharmacology and toxicological studies with amoxycillin, talampicillin, and ampicillin and a clinical trial of parenteral amoxycillin in serious hospital infections. Drugs Exptl Clin Res, 5:29-139.
55. Leigh DA, Nash JG. 1979. Parenteral amoxycillin treatment of severe infections in hospitalized patients. J Antimicrob Chemother, 5:109-12.
56. Lode H, Müller C, Bomer K, et al. 1992. Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers. Antimicrob Agents Chemother, 36:144-9.
57. Lode H, Von der Höh N, Ziege S, et al. 2001. Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. Scand J Infect Dis, 33:899-903.
58. Louie TJ, Chubb H, Bow EJ, et al. 1985. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient. Rev Infect Dis, 7(Suppl 4):S747-S761.
59. Nikolaeva IV, Anokhin VA, Bondarenko VM, et al. 2001. [Drug resistance of Staphylococcus aureus strains, isolated from children with intestinal dysbacteriosis]. Zh Mikrobiol Epidemiol Immunobiol, 1:9-13.
60. Nilsson-Ehle I, Nord CE, Ursing B, 1985. Ceftriaxone: pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infections. Scand J Infect Dis, 17:77-82.
61. Nord CE. 1993. The effect of antimicrobial agents on the ecology of the human intestinal microftora. Vet Microbiol, 35:193-7.
62. Nord CE. 2008. Antimicrobial susceptibility patterns of anaerobic bacteria in Europe (abstract). 9th Biennial Congress of the Anaerobe Society of the Americas, Long Beach, CA. p. 137.
63. Nord CE, Bergan T, Aase S. 1986a. Impact of azlocillin on the colon microflora. Scand J Infect Dis, 18:163-6.
64. Nord CE, Bergan T, Thorsteinsson SB. 1989. Impact of ticarcillin/ clavulanate on the intestinal microflora. J Antimicrob Chemother, 24(Suppl B):221-6.
65. Nord CE, Brismar B, Kasholm-Tengve B, et al. 1992. Effect of piperacillin/tazobactam therapy on intestinal microflora. Scand J Infect Dis, 24:209-13.
66. Nord CE, Brismar B, Kasholm-Tengve B, et al. 1993. Effect of piperacillin/tazobactam treatment on human bowel microflora. J Antimicrob Chemother, 31 (Suppi A): 61-5.
67. Nord CE, Edlund C. 1990. Impact of antimicrobial agents on human intestinal microflora. J Chemother, 2:218-37.
68. Nord CE, Farrell DJ, Leclercq R. 2004. Impact of ketolides on resistance selection and ecologic effects during treatment for respiratory tract infections. Microb Drug Resist, 10:255-63.
69. Nord CE, Heimdahl A, Kager L, et al. 1984a. The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans. Rev Infect Dis, 6(Suppl 1):S270-S275.
70. Nord CE, Heimdahl A, Lundberg C, et al. 1987. Impact of cefaclor on the normal human oropharyngeal and intestinal microffora. Scand J Infect Dis, 19:681-5.
71. Nord CE, Kager L, Heimdahl A. 1984b. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med, 76:99-106.
72. Nord CE, Kager L, Malmborg AS. 1988. Effects of antimicrobial prophylaxis on colonization resistance. J Hosp Infect, 11 (Suppl A):259-64.
73. Nord CE, Kager L, Philipson A, et al. 1985. Effect of imipenem/ cilastatin on the colonic microflora. Rev Infect Dis, 7(Suppl 3):S432-S434.
74. Nord CE, Lahnborg G. 1994. Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections. Eur J Surg Suppl, (573):45-9.
75. Nord CE, Meurling L, Russo RL, et al. 2003. Effect of garenoxacin on eubacteria in the normal intestinal microflora when administered concomitantly with digoxin. J Chemother, 15:244-7.
76. Nord CE, Rasmanis G, Wablund E. 2006a. Effect of dalbavancin on the normal intestinal microflora. J Antimicrob Chemother, 5 8:627-31.
77. Nord CE, Sillerstrom E, Wahlund E. 2006b. Effect of tigecycline on normal oropharyngeal and intestinal microflora. Antimicrob Agents Chemother, 50:3375-80.
78. Noverr MC, Huffnagle GB. 2005. The 'microflora hypothesis' of allergic diseases. Clin Exp Allergy, 35:1511-20.
79. Oh H, Nord CE, Barkholt L, et al. 2000. Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone. Infection, 28:272-7.
80. Peck JJ, Fuchs PC, Gustafson ME. 1984. Antimicrobial prophylaxis in elective colon surgery. Experience of 1,035 operations in a community hospital. Am J Surg, 147:63 3-7.
81. Pecquet S, Andremont A, Tancrede C. 1987. Effect of oral ofloxacin on fecal bacteria in human volunteers. Antimicrob Agents Chemother, 31:124-5.
82. Pletz MW, Rau M, Bulitta J, et al. 2004. Ertapenem. pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrob Agents Chemother, 48:3765-72.
83. Prantera C, Scribano ML, Berto E, et al. 1997. Antibiotic use in Crohn's disease: why and how? BioDrugs, 8:293-306.
84. Pultz NJ, Donskey CJ. 2005. Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice. Antimicrob Agents Chemother, 49:3529-32.
85. Rafii F, Park M, Bryant AE, et al. 2008. Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfingens. Antimicrob Agents Chemother, 52:895-900.
86. Rafii F, Park M, Novak JS. 2005. Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones. Antimicrob Agents Chemother, 49:488-92.
87. Ritz M, Lode H, Fassbender M, et al. 1994. Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora. Antimicrob Agents Chemother, 38:455-9.
88. Rowland IR. 1995. Toxicology of the colon. Role of intestinal microflora. In: Gibson GR, Macfarlane GT (ed). Human Colonic Bacteria. Boca Raton, FL: CRC Press, pp. 155-74.
89. Schröder O, Gerhard R, Stein J. 2006. [Antibiotic-associated diarrhea]. Z Gastroenterol, 44:193-204.
90. Stark C, Edlund C, Hedberg M, et al. 1995. Induction of beta-lactamase by cefoxitin in anaerobic intestinal rnicroflora. Ear J Clin Microbiol Infect Dis, 14:18-24.
91. Stark CA, Adamsson I, Edlund C, et al. 1996. Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection. J Antimicrob Chemother, 38:927-39.
92. Stark CA, Edlund C, Sjöstedt S, et al. 1993. Antimicrobial resistance in human oral and intestinal anaerobic microfloras. Antimicrob Agents Chemother, 37:1665-9.
93. Sullivan A, Edlund C, Nord CE. 2001 a. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis, 1: 101-14.
94. Sullivan A, Edlund C, Svenungsson B, et al. 2001b. Effect of perorally administered pivmecillinam on the normal oropharyngeal, intestinal and skin microflora. J Chemother, 13:299-308.
95. van der Waaij D. 1985. Selective decontamination of the digestive tract with oral aztreonam and temocillin. Rev Infect Dis, 7(Suppl 4): S628-S634.
96. van der Waaij D, Nord CE. 2000. Development and persistence of multiresistance to antibiotics in bacteria; an analysis and a new approach to this urgent problem. Int J Antimicrob Agents, 16:191-7.
97. Vollaard EJ, Clasener HA, Janssen AJ. 1992. Influence of pefloxacin on microbial colonization resistance in healthy volunteers. Eur J Clin Microbiol Infect Dis, 11:257-60.
98. Wagner RD, Johnson SJ, Cerniglia CE. 2008. An in vitro model of colonization resistance by the enteric microbiota: effects of antimicrobial agents used in food-producing knimals. Antimicrob Agents Chemother, 52:1230-7.
99. Winberg J, Herthelius-Elman M, Möllby R, et al. 1993. Pathogenesis of urinary tract infection - experimental studies of vaginal resistance to colonization. Pediatr Nephrol, 7:509-14.
100. Zhang X, McDaniel AD, Wolf LE, et al. 2000. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis, 181:664-70.